Overview

Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
0
Participant gender:
All
Summary
Comparison between the effect of aliskiren/amlodipine combination with amlodipine monotherapy on ankle-foot volume in hypertensive patients. It will be enrolled male or female outpatients, aged 18-65 years.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Pavia
Treatments:
Amlodipine
Criteria
Inclusion Criteria:

- diastolic blood pressure > 95 mmHg and < 110 mmHg

- systolic blood pressure > 140 mmHg and < 180 mmHg

- no amlodipine therapy for the previous 6 months

Exclusion Criteria:

- diastolic blood pressure > 110 mmHg and or

- systolic blood pressure > 180 mmHg

- secondary hypertension

- heart failure

- diabetes mellitus

- liver or kidney diseases